Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.

Lubasch A, Ziege S, Brodersen B, Borner K, Koeppe P, Lode H.

Clin Microbiol Infect. 2003 Jul;9(7):670-7.

2.
3.
4.

Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.

Van der Auwera P, Klastersky J, Lieppe S, Husson M, Lauzon D, Lopez AP.

Antimicrob Agents Chemother. 1986 Feb;29(2):230-4.

5.
6.

Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.

Mimoz O, Jacolot A, Padoin C, Caillon J, Louchahi K, Tod M, Samii K, Petitjean O.

J Antimicrob Chemother. 1997 Mar;39(3):363-9.

7.

Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.

Visalli MA, Bajaksouzian S, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 1997 Jul;41(7):1475-81.

9.

Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers.

Prieto J, Aguilar L, Fuentes F, Giménez MJ, Alou L, Dal-Ré R, Sörgel F, Frías J.

Int J Antimicrob Agents. 2001 Sep;18(3):231-8.

PMID:
11673035
10.

Oral bioavailability of trovafloxacin with and without food in healthy volunteers.

Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J.

J Antimicrob Chemother. 1997 Jun;39 Suppl B:87-92.

11.

Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.

Mimoz O, Jacolot A, Padoin C, Tod M, Samii K, Petitjean O.

J Antimicrob Chemother. 1998 Mar;41(3):367-72.

12.

In vitro activity of trovafloxacin in combination with ceftazidime, meropenem, and amikacin.

Milatovic D, Wallrauch C.

Eur J Clin Microbiol Infect Dis. 1996 Aug;15(8):688-93.

PMID:
8894583
13.
14.

Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.

García-Calvo G, Parra A, Aguilar L, Ponte C, Giménez MJ, Carcas A, Kinzig-Schippers M, Soriano F.

Antimicrob Agents Chemother. 2001 Jun;45(6):1876-8.

15.
16.

An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin.

Purkins L, Oliver SD, Willavize SA.

Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):431-3.

PMID:
9758288
20.

Pharmacokinetics and metabolism of single oral doses of trovafloxacin.

Vincent J, Teng R, Dalvie DK, Friedman HL.

Am J Surg. 1998 Dec;176(6A Suppl):8S-13S.

PMID:
9935250
Items per page

Supplemental Content

Support Center